{"name":"Trigemina, Inc","slug":"trigemina-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUUJTd3ZqNVZUY3gyM0VTU0tVX1ppTlo3YmwtNkJQalFwcnRSMHF2SjZPcUVBaWJ3UzZBTzNGVzdEeVYyYURMVmZrWGpBcFBudk95RnJfTHRoM1VqSmt5OGh6QjFpX21ELTdmYVV3b3hZMmd2SFRybTdaS3V2VW1Cc0lDU1M5X2FTOENnUmI2MFE2YzJKN0IwenBtRmtGZ3lRVkM4eTJINDA4Z1JqTkJaMkJRWGRQZGlXNTJxTEVfS2E?oc=5","date":"2026-03-26","type":"trial","source":"Stock Titan","summary":"Tonix (NASDAQ: TNXP) doses first subject in TNX-1900 migraine study - Stock Titan","headline":"Tonix (NASDAQ: TNXP) doses first subject in TNX-1900 migraine study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5BdlhmT2NyRk45RElMZE5fOTRrYTFXSy1KQ3ctRWNGVGlteWVkTzAwOEgxMkZfMmYybExyUUZKYnRNeUdkcnl4djA4ZUNQRmRRYjVHbWhnSE5SVjVadGfSAWNBVV95cUxPdFplZ2w1TzQwRndvM0hiSzRPR1czOEkzOGtWQXRDbTNQUkdZOUR3NWxGTEFEOTZGaDRpRl9teXVPUmJEWi15VDVqdTFfNy1QTHBxYmVZTWx1LTA5dDFoOXBod0E?oc=5","date":"2026-03-26","type":"trial","source":"Bitget","summary":"Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine ","headline":"Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9Fa2hBWlZaNXI3VTh5ZUhRdHZLZldTal9ZbnUxQUlza0JPTF9HU1doU3VUd0Y3VXdiWE5JNWk4UWNudFBjTnlDNGMtazhOdXBhU3V2Z0RxQjFqWDJ4eGZMbV9tb2ktQjFNU21VSk1sOHFod0twdUVIVmhCWWlFZw?oc=5","date":"2025-08-19","type":"regulatory","source":"Yahoo Finance","summary":"NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment - Yahoo Finance","headline":"NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-28","type":"regulatory","source":"expresspharma.in","summary":"Alembic Pharmaceuticals gains USFDA final approval for Carbamazepine Extended-Release Tablets - expresspharma.in","headline":"Alembic Pharmaceuticals gains USFDA final approval for Carbamazepine Extended-Release Tablets","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZ1NRY1Q1YXdYcUR3UENsQjlsOWxCV2U0M19iUHBBSzFyOFQxVDNWT1p1a2JQeUVMX0ZoQVJuUGlCd29RRzNSeW54ZkhBejVyRF8yVndIeXMtcXExY2QxX1h1U1dWaWNUbzFPbnNjTDFNLTlJRHNaeVhFZVltd3VXaDNGNGZXY3VmV1I1Wm5fRkRtbUVVM0N0WnRCWmZyR0hORFl4eGE4ZlRFLVlhMDVKbHUybHBXZkFMUTZ2Zk5KUlY3SjhjZnhOMTI5UldsTmlvS05Eb1BoYnJ5eXRk?oc=5","date":"2024-12-11","type":"regulatory","source":"Business Wire","summary":"Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million) - Business Wire","headline":"Noema Pharma extends Series B financing round, closing at CHF 130 Million ($147 Million)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQWjYyQWVkUVhEYWJPNmloOGtiMV9mUDktUjZPMTFaY0VmVlNCYmpHWUNfcFdrZVpOM1BScVVMM2FQaldHMmpzQ0w3Ni1QektQR2VVX3FWTGVrZDlSd0ktTGxodFk2U09Ha2FRYnhjbklmQjNLcFYzQlU3MU9MTmdRV0ZxOVVTZ1FDM3JBLWlEMXMyMGdqVHo2RkFvRGc4c0tXcVlBS2hWM1JrNHVqc2RUN3JCc01xYTdjMV84WWliMlUzY3lrQW5MOThpVFA5SWg3?oc=5","date":"2022-11-17","type":"deal","source":"Healio","summary":"Kriya acquires Redpin Therapeutics, adds gene therapies for epilepsy, trigeminal neuralgia - Healio","headline":"Kriya acquires Redpin Therapeutics, adds gene therapies for epilepsy, trigeminal neuralgia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRWVKQmZEVE5VWXJkNGNJZ3FvaEItRzlxZDluMEtKWHliRmJoREFBTm02UW82NWZLV2dtTklFNVpRMFNmUFZBVlFyT19Ea1hRem5ocl8xTVo4aURIc2lKSFBnVFhkandMV2VBRUFLZlE4M2tuMXAzOUFQMEMwTF9HcmxwVXV3ZWJMMmFDOXY5WkRHX1dVRVlBdTV5QUVqRmljSDRtdlZ4X0MzQjdvMkVGUXpoQU5YX0N4S0x3V1BiYTlFUG8?oc=5","date":"2022-10-18","type":"pipeline","source":"Medical Professionals Reference","summary":"Basimglurant Fast Tracked for Pain Associated with Trigeminal Neuralgia - Medical Professionals Reference","headline":"Basimglurant Fast Tracked for Pain Associated with Trigeminal Neuralgia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNcmRfMl93VUdfNzdLYVhPZHNMQi1VTV9tb213M2kyWE9YNUhZLWRXdFNFcEFqeUMwcWZrcUl0aUpZNm9sZ3BiRnFSbWExTGt1blBZaGhFU0h5Z3pEaXV6VFpqQ0c4MEdTUGNkUXhPakpsZC1fVEpHV2dtSmlvOXl3NGRR?oc=5","date":"2022-02-01","type":"pipeline","source":"Ophthalmology Times","summary":"Nasal spray treating dry eye disease - Ophthalmology Times","headline":"Nasal spray treating dry eye disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQd0lSQk5NRkh1QzNSYlhtcDhQbVdRWjFia0tKMUhBUzBUX3Z4TGlSNS1jU2RVZkU4OUplbUI4ck1zQWZjdm1YaGRhNmM4WTBkazhiX2Y5YTJKLVVFYWMxTVBlOTFJZ1lmMmxFa1FKVVhzRkoxdHQ0VGtwbFNPRHp4X08wYm5yZw?oc=5","date":"2020-11-11","type":"pipeline","source":"Straits Research","summary":"Trigeminal Neuralgia (TN) Treatment Market Size, Top Share, Report to 2033 - Straits Research","headline":"Trigeminal Neuralgia (TN) Treatment Market Size, Top Share, Report to 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPcmpUYkFyczNqRWJlaVpZMlRzVjJjUjV1bnVuVXhiUGJ6bWU4c29xUHM0ekZLUGFDNGJlQnRHTlQxSkd2bHZXeHAwTF8tSll1VU0yb3A5YlJwMUdBRnVBR0pUdUFZWk5PaklpOVlvYmE5Ujg2NXRZRTViRG1sYnZiZkVxcFZELWU5S3UzeHloOGRwXzF3TDFKNW00bXFtbUVrMkVfRzJjdmFRZGM0UnlNSEkxek1OS08tTlV1d0V5V0VCTlYwLUtTRjd6QTR2Yk1vakozRVEtS0NrcFhhZFZtTWhxRHFSRGIwZS1UMWl1TkxBalRFa2M0QWt2QlZUaXB3eEdQY1I4bTRmNjNfVEw2Y1FNal9pdnhrcDNhNkZKLUlqY3lfMUtzZ1hn?oc=5","date":"2019-07-01","type":"trial","source":"PR Newswire","summary":"Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant, Oral CGRP Receptor Antagonist, for Treatment Refractory Trigeminal Neuralgia - PR Newswire","headline":"Biohaven Enrolls First Patient in Phase 2 Clinical Trial of Rimegepant, Oral CGRP Receptor Antagonist, for Treatment Ref","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPNFFvWlZSSGNaMzhEeXJIb0htNmNjdmUzanVsV0NRbGl4bzJKUDFkODhYby10YU50OGhwZ0hWSmNiNGlsRkplSi11aElfcG1uLUMtMTdqbXkxaWcwSXVscUl2Vi1wbTItWGhMT0EzOHR3OE42ZVlhWGdfMGM4MVVfZk5Fa1UyOENiUldHZ3pqa1Y3T3ZZLUYydjM5bll2Zw?oc=5","date":"2017-08-10","type":"pipeline","source":"European Medical Journal","summary":"Editor’s Pick : Emerging Treatment Options in Migraine - European Medical Journal","headline":"Editor’s Pick : Emerging Treatment Options in Migraine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPUWdZTWllZ0JTRU8yRTVNQjNpUGZTNDlUeWZvOTF5WmlLNzdYSnRkWWtuTkEyaTFMb3l2TmhaWFlnWmdzMEVYTmNhLWtsbFJoS2dtenpLUW9kdEgwZl9WOU8tY25zNy16alpmLU05YksxTGJ6T3c0emJ6UEV6eEc1NWlFSU43bEY5R2Q4UWItWEgyajRNS2dRU3JETTIzeXBNTjJrcUo3eDFzaW82R2xRWFVYNjJGTDM1Y05mY0Fn?oc=5","date":"2015-01-11","type":"pipeline","source":"Biogen","summary":"Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals - Biogen","headline":"Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}